questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérocycliques avec 4 noyaux ou plus
Ergotamines
Ergotamines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Molecular Docking Simulation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ergotamines : Questions médicales les plus fréquentes",
"headline": "Ergotamines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ergotamines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-26",
"dateModified": "2025-03-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ergotamines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"url": "https://questionsmedicales.fr/mesh/D006576",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"code": {
"@type": "MedicalCode",
"code": "D006576",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Bromocriptine",
"alternateName": "Bromocriptine",
"url": "https://questionsmedicales.fr/mesh/D001971",
"about": {
"@type": "MedicalCondition",
"name": "Bromocriptine",
"code": {
"@type": "MedicalCode",
"code": "D001971",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergocornine",
"alternateName": "Dihydroergocornine",
"url": "https://questionsmedicales.fr/mesh/D025441",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergocornine",
"code": {
"@type": "MedicalCode",
"code": "D025441",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergocristine",
"alternateName": "Dihydroergocristine",
"url": "https://questionsmedicales.fr/mesh/D025442",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergocristine",
"code": {
"@type": "MedicalCode",
"code": "D025442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "alpha-Dihydroergocryptine",
"alternateName": "Dihydroergocryptine",
"url": "https://questionsmedicales.fr/mesh/D025443",
"about": {
"@type": "MedicalCondition",
"name": "alpha-Dihydroergocryptine",
"code": {
"@type": "MedicalCode",
"code": "D025443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergotamine",
"alternateName": "Dihydroergotamine",
"url": "https://questionsmedicales.fr/mesh/D004087",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergotamine",
"code": {
"@type": "MedicalCode",
"code": "D004087",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergotoxine",
"alternateName": "Dihydroergotoxine",
"url": "https://questionsmedicales.fr/mesh/D004088",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergotoxine",
"code": {
"@type": "MedicalCode",
"code": "D004088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mésilate d'alcaloïdes hydrogénés de l'ergot",
"alternateName": "Ergoloid Mesylates",
"url": "https://questionsmedicales.fr/mesh/D004877",
"about": {
"@type": "MedicalCondition",
"name": "Mésilate d'alcaloïdes hydrogénés de l'ergot",
"code": {
"@type": "MedicalCode",
"code": "D004877",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.400.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ergotamine",
"alternateName": "Ergotamine",
"url": "https://questionsmedicales.fr/mesh/D004878",
"about": {
"@type": "MedicalCondition",
"name": "Ergotamine",
"code": {
"@type": "MedicalCode",
"code": "D004878",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Ergotamines",
"alternateName": "Ergotamines",
"code": {
"@type": "MedicalCode",
"code": "D004879",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Manoj B Kudupoje",
"url": "https://questionsmedicales.fr/author/Manoj%20B%20Kudupoje",
"affiliation": {
"@type": "Organization",
"name": "Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States."
}
},
{
"@type": "Person",
"name": "Eric S Vanzant",
"url": "https://questionsmedicales.fr/author/Eric%20S%20Vanzant",
"affiliation": {
"@type": "Organization",
"name": "Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States."
}
},
{
"@type": "Person",
"name": "Kyle R McLeod",
"url": "https://questionsmedicales.fr/author/Kyle%20R%20McLeod",
"affiliation": {
"@type": "Organization",
"name": "Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States."
}
},
{
"@type": "Person",
"name": "Alexandros Yiannikouris",
"url": "https://questionsmedicales.fr/author/Alexandros%20Yiannikouris",
"affiliation": {
"@type": "Organization",
"name": "Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States."
}
},
{
"@type": "Person",
"name": "Wiebke Rudolph",
"url": "https://questionsmedicales.fr/author/Wiebke%20Rudolph",
"affiliation": {
"@type": "Organization",
"name": "a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Molecular docking, ADMET and molecular dynamics simulation revealed metralindole as a multitargeted inhibitor for division kinases.",
"datePublished": "2023-04-17",
"url": "https://questionsmedicales.fr/article/37075433",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1519-6984.271688"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of 4-hydroxyphenylpyruvate dioxygenase inhibitors by virtual screening, molecular docking, molecular dynamic simulation.",
"datePublished": "2023-05-03",
"url": "https://questionsmedicales.fr/article/37052266",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jsfa.12629"
}
},
{
"@type": "ScholarlyArticle",
"name": "Synthesis, anticholinesterase activity, molecular docking, and molecular dynamic simulation studies of 1,3,4-oxadiazole derivatives.",
"datePublished": "2022-08-16",
"url": "https://questionsmedicales.fr/article/35972839",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ardp.202200294"
}
},
{
"@type": "ScholarlyArticle",
"name": "Repurposing antiviral drugs against HTLV-1 protease by molecular docking and molecular dynamics simulation.",
"datePublished": "2022-05-25",
"url": "https://questionsmedicales.fr/article/35612907",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/07391102.2022.2078411"
}
},
{
"@type": "ScholarlyArticle",
"name": "In Silico Study on the Interactions, Molecular Docking, Dynamics and Simulation of Potential Compounds from",
"datePublished": "2023-01-22",
"url": "https://questionsmedicales.fr/article/36770785",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules28031117"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"item": "https://questionsmedicales.fr/mesh/D006576"
},
{
"@type": "ListItem",
"position": 5,
"name": "Ergotamines",
"item": "https://questionsmedicales.fr/mesh/D004879"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ergotamines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ergotamines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ergotamines",
"description": "Comment diagnostiquer une migraine ?\nQuels tests sont utilisés pour les migraines ?\nLes ergots sont-ils prescrits pour d'autres maux de tête ?\nQuels critères sont utilisés pour le diagnostic ?\nLes antécédents familiaux influencent-ils le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Molecular+Docking+Simulation&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ergotamines",
"description": "Quels sont les symptômes d'une migraine ?\nLes migraines provoquent-elles des vomissements ?\nY a-t-il des signes avant-coureurs de migraine ?\nLes migraines peuvent-elles causer des vertiges ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Molecular+Docking+Simulation&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ergotamines",
"description": "Comment prévenir les migraines ?\nLes changements alimentaires aident-ils à prévenir les migraines ?\nLe stress influence-t-il la fréquence des migraines ?\nLes exercices physiques aident-ils à prévenir les migraines ?\nLes thérapies alternatives sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Molecular+Docking+Simulation&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ergotamines",
"description": "Comment les ergots soulagent-ils les migraines ?\nQuels sont les effets secondaires des ergots ?\nLes ergots sont-ils efficaces pour tous les patients ?\nPeut-on combiner les ergots avec d'autres médicaments ?\nQuelle est la voie d'administration des ergots ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Molecular+Docking+Simulation&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ergotamines",
"description": "Quelles sont les complications possibles des migraines ?\nLes migraines peuvent-elles entraîner des AVC ?\nLes migraines chroniques ont-elles des conséquences ?\nLes migraines peuvent-elles causer des problèmes cognitifs ?\nComment gérer les complications des migraines ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Molecular+Docking+Simulation&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ergotamines",
"description": "Quels sont les facteurs de risque des migraines ?\nL'âge influence-t-il le risque de migraines ?\nLes changements hormonaux affectent-ils les migraines ?\nLe manque de sommeil est-il un facteur de risque ?\nLes habitudes alimentaires influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Molecular+Docking+Simulation&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une migraine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique des symptômes et des examens neurologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les migraines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie comme l'IRM peuvent être utilisés pour exclure d'autres causes."
}
},
{
"@type": "Question",
"name": "Les ergots sont-ils prescrits pour d'autres maux de tête ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont principalement prescrits pour les migraines, pas pour d'autres types de céphalées."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la fréquence, la durée et l'intensité des crises de migraine."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de migraines peuvent augmenter la probabilité de diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une migraine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs pulsatiles, des nausées et une sensibilité à la lumière."
}
},
{
"@type": "Question",
"name": "Les migraines provoquent-elles des vomissements ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vomissements peuvent accompagner les migraines chez certains patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes avant-coureurs de migraine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des troubles visuels ou des picotements peuvent précéder une migraine."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles causer des vertiges ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes ressentent des vertiges ou des étourdissements pendant une crise."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir les migraines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs connus, maintenir un mode de vie sain et prendre des médicaments préventifs."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires aident-ils à prévenir les migraines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains aliments peuvent déclencher des migraines, leur évitement peut aider."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la fréquence des migraines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress est un déclencheur courant des migraines et sa gestion est cruciale."
}
},
{
"@type": "Question",
"name": "Les exercices physiques aident-ils à prévenir les migraines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité physique régulière peut réduire la fréquence et l'intensité des migraines."
}
},
{
"@type": "Question",
"name": "Les thérapies alternatives sont-elles efficaces ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies comme l'acupuncture peuvent aider à réduire la fréquence des migraines."
}
},
{
"@type": "Question",
"name": "Comment les ergots soulagent-ils les migraines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les ergots agissent en constrictant les vaisseaux sanguins et en réduisant l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des ergots ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des vertiges et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Les ergots sont-ils efficaces pour tous les patients ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité peut varier et certains patients peuvent ne pas y répondre."
}
},
{
"@type": "Question",
"name": "Peut-on combiner les ergots avec d'autres médicaments ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il est important de consulter un médecin pour éviter les interactions."
}
},
{
"@type": "Question",
"name": "Quelle est la voie d'administration des ergots ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les ergots peuvent être administrés par voie orale, nasale ou injectable selon le cas."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des migraines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles de l'humeur, des problèmes de sommeil et des AVC."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles entraîner des AVC ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les migraines avec aura peuvent augmenter le risque d'accident vasculaire cérébral."
}
},
{
"@type": "Question",
"name": "Les migraines chroniques ont-elles des conséquences ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent affecter la qualité de vie et entraîner des troubles psychologiques."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles causer des problèmes cognitifs ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que les migraines fréquentes peuvent affecter la cognition."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications des migraines ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire incluant médecins et psychologues est souvent nécessaire."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des migraines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, le sexe féminin, et le stress."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de migraines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les migraines sont plus fréquentes chez les jeunes adultes et les femmes d'âge moyen."
}
},
{
"@type": "Question",
"name": "Les changements hormonaux affectent-ils les migraines ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les fluctuations hormonales, notamment pendant le cycle menstruel, peuvent déclencher des migraines."
}
},
{
"@type": "Question",
"name": "Le manque de sommeil est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le manque de sommeil peut augmenter la fréquence et l'intensité des migraines."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains aliments et boissons peuvent déclencher des migraines chez certaines personnes."
}
}
]
}
]
}
Lung cancer is the most common type of cancer in the world, and alone, in 2020, almost 2.21 million new cases were diagnosed, with 1.80 million deaths, and are increasing daily. Non-small cell lung (N...
4-Hydroxyphenylpyruvate dioxygenase (HPPD) herbicides control broadleaf and gramineous weeds with better crop safety for corn, sorghum and wheat. Multiple screening models in silico have been establis...
Topomer comparative molecular field analysis (CoMFA) combined with topomer search technology and Bayesian, genetic approximation functions (GFA) and multiple linear regression (MLR) models generated b...
In this study, five compounds were obtained through multiple quantitative structure-activity relationship screening. Molecular docking and MD experiments showed that the constructed approach had good ...
Two new series of 1,3,4-oxadiazoles bearing pyridine and thiazole heterocycles (4a-h and 5a-h) were synthesized (2,5-disubstituted-1,3,4-oxadiazoles). The structures of these newly synthesized compoun...
Human T-cell leukemia virus type I (HTLV-1) belongs to the delta retrovirus family and the etiological agent of adult T-cell leukemia (ATL(. While the current HTLV-1 therapy, relies on using Zidovudin...
Cancer is characterized by the abnormal development of cells that divide in an uncontrolled manner and further take over the body and destroy the normal cells of the body. Although several therapies a...
Glioblastoma (GBM) is a WHO Grade IV tumor with poor visibility, a high risk of comorbidity, and exhibit limited treatment options. Resurfacing from second-rate glioma was originally classified as eit...
The study aimed to screen prospective molecular targets of BCC and potential natural lead candidates as effective binders by computational modeling, molecular docking, and dynamic (MD) simulation stud...
Regarding the importance of N-degron pathway in protein degradation network, the adaptor protein ClpS recognizes the substrates bearing classical N-degrons, and delivers them to caseinolytic protease ...
With the continuous improvement of anticancer drugs, the condition of patients has been controlled to a certain extent, but the problem that still needs to be urgently solved is that most anticancer d...
The interaction of the SN38 with folic acid and isoproterenol hydrochloride was rapidly determined by molecular docking and molecular dynamics simulation methods. We used Discovery Studio software to ...
Inhibition of acetylcholinesterase (AChE) is a crucial target in the treatment of Alzheimer's disease (AD). Common anti-acetylcholinesterase drugs such as Galantamine, Rivastigmine, Donepezil, and Tac...